000 01527 a2200397 4500
005 20250513011843.0
264 0 _c19830311
008 198303s 0 0 eng d
022 _a0009-8981
024 7 _a10.1016/0009-8981(82)90028-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMÃ¥nsson, J E
245 0 0 _aThe use of galactosylceramides with uniform fatty acids as substrates in the diagnosis and carrier detection of Krabbe disease.
_h[electronic resource]
260 _bClinica chimica acta; international journal of clinical chemistry
_cDec 1982
300 _a127-33 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCerebrosides
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGalactosidases
_xblood
650 0 4 _aGalactosylceramidase
_xblood
650 0 4 _aGalactosylceramides
_xmetabolism
650 0 4 _aGenetic Carrier Screening
_xmethods
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aLactosylceramides
_xmetabolism
650 0 4 _aLeukocytes
_xenzymology
650 0 4 _aLeukodystrophy, Globoid Cell
_xenzymology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aStructure-Activity Relationship
650 0 4 _aSubstrate Specificity
700 1 _aSvennerholm, L
773 0 _tClinica chimica acta; international journal of clinical chemistry
_gvol. 126
_gno. 2
_gp. 127-33
856 4 0 _uhttps://doi.org/10.1016/0009-8981(82)90028-6
_zAvailable from publisher's website
999 _c7150871
_d7150871